Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jun:93:106366.
doi: 10.1016/j.leukres.2020.106366. Epub 2020 Apr 30.

Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia

S Paneesha  1   2 , G Pratt  1   2 , H Parry  1   2 , P Moss  1   2
Affiliations
Case Reports

Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia

S Paneesha et al. Leuk Res. 2020 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare they have no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart of blood count in each patient. The x-axis shows the date (not to scale) and the period of Covid-19 infection is shown in green. The y-axis shows the total white cell count on the left-hand scale (WBC; x109/l) whilst the hemoglobin (HB; g/L), platelet count (PLT; x109/l) and lymphocyte count (LYMPH; x109/l) are shown on the right hand scale. HB is dark blue; WBC is red; Platelet count is light blue and Lymphocyte count is yellow. A, Case report 1; B, Case Report 2; C, Case Report 3 and D, Case Report 4.
Fig. 2
Fig. 2
Covid-induced lymphocytosis. The peripheral lymphocyte count is shown for each patient at the most recent outpatient clinic prior to onset of SAR-CoV-2 infection and also the peak value during Covid-19 infection. The y-axis is a logarithmic scale.
See this image and copyright information in PMC

References

    1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., et al. China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. - PMC - PubMed
    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. - PMC - PubMed
    1. Forconi F., Moss P. Perturbation of the normal immune system in patients with CLL. Blood. 2015;126(July (5)):573–581. - PubMed
    1. Jin Xh, Zheng Ki, Pan Kh, Xie Yp, Zheng Mh. COVID-19 in a patient with chronic lymphocytic leukaemia. Lancet Haematol. 2020;7(April (4)):e351–e352. - PMC - PubMed
    1. Treon S.P., Castillo J., Skarbnik A.P., Soumerai J.D., Ghobrial I.M., et al. The BTK-inhibitor ibrutinib may protect against pulmonary injury in COVID-19 infected patients. Blood. 2020;(April):17. pii: blood.2020006288. - PMC - PubMed